biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Corporate Presentation - DrDR Is AWOL!!

<< Previous

Bullboard Posts

Next >>

Comment by narmacon Jan 25, 2023 10:04am

144 Views

Post# 35244912

RE:RE:Corporate Presentation - DrDR Is AWOL!!

We have 10 souls in senior management positions!

We have 4 souls plus DrDr on the BoDs.

We have 4 more souls on the Medical Advisory Board.

We have 4 more souls plus a senior manager on the Scientific Advisory board.

Lots of talent and extra cost to operate yet the result is no advancement,,,!!

Things have to be shaken up !!!!!

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China